{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:21:19Z","timestamp":1764645679711,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Multimodale Schmerztherapien erfolgen \u00fcblicherweise im Rahmen von mehrw\u00f6chigen Gruppentherapien und basieren auf einem generell aktivierenden Ansatz. Durch die Besonderheit einer Belastungsintoleranz mit postexertioneller Malaise (PEM) bei Patient:innen mit postviralen Syndromen muss in diesen F\u00e4llen eine k\u00f6rperliche sowie psychische \u00dcberlastung dringend vermieden werden. Diese Aspekte k\u00f6nnen in g\u00e4ngigen schmerzmedizinischen Therapiekonzepten jedoch nur unzureichend ber\u00fccksichtigt werden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodik<\/jats:title>\n                <jats:p>Zusammenfassung der aktuellen Literatur und Darstellung klinischer Besonderheiten sowie Vorstellung eines therapeutischen Modellprojekts f\u00fcr eine interdisziplin\u00e4re multimodale Schmerztherapie bei postviralen Syndromen mit PEM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Modellkonzept<\/jats:title>\n                <jats:p>Das vorgestellte Modellkonzept beschreibt ein der individuellen Belastbarkeit angepasstes tagesklinisches Behandlungssetting f\u00fcr die multimodale Schmerztherapie mit Minimierung des Risikos einer belastungsinduzierten Zustandsverschlechterung.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00482-023-00761-2","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T16:01:34Z","timestamp":1697817694000},"page":"183-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interdisziplin\u00e4re multimodale Schmerztherapie bei postviralen Syndromen und ME\/CFS","Interdisciplinary multimodal pain therapy in postviral syndromes and ME\/CFS"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-9874","authenticated-orcid":false,"given":"Benjamin","family":"Luchting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Eigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Stojanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Warlitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Haegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Neuwirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"Mihatsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Peter","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"761_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00482-008-0741-x","volume":"23","author":"B Arnold","year":"2009","unstructured":"Arnold\u00a0B, Brinkschmidt\u00a0T, Casser\u00a0HR et\u00a0al (2009) Multimodal pain therapy: principles and indications. Schmerz 23:112\u2013120","journal-title":"Schmerz"},{"key":"761_CR2","doi-asserted-by":"publisher","first-page":"1090747","DOI":"10.3389\/fneur.2023.1090747","volume":"14","author":"H Bonilla","year":"2023","unstructured":"Bonilla\u00a0H, Quach\u00a0TC, Tiwari\u00a0A et al (2023) Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-coV\u20112 infection (PASC): results from a\u00a0post-COVID-19 multidisciplinary clinic. Front Neurol 14:1090747","journal-title":"Front Neurol"},{"key":"761_CR3","volume-title":"Symptoms and Diagnosis of ME\/CFS","author":"Centers for Disease Control and Prevetion","year":"2021","unstructured":"Centers for Disease Control and Prevetion (2021) Symptoms and Diagnosis of ME\/CFS. CDC, In"},{"key":"761_CR4","doi-asserted-by":"crossref","unstructured":"Cotler J, Holtzman C, Dudun C et al (2018) A brief questionnaire to assess post-exertional malaise. Diagnostics (basel) 8:","DOI":"10.3390\/diagnostics8030066"},{"key":"761_CR5","doi-asserted-by":"publisher","first-page":"e221809","DOI":"10.1001\/jamahealthforum.2022.1809","volume":"3","author":"DM Cutler","year":"2022","unstructured":"Cutler\u00a0DM (2022) The costs of long COVID. Jama Health Forum 3:e221809","journal-title":"Jama Health Forum"},{"key":"761_CR6","volume-title":"Synkopen, S1-Leitlinie","author":"R Diehl","year":"2020","unstructured":"Diehl\u00a0R, Haubrich\u00a0C, Steinhoff\u00a0B et al (2020) Synkopen, S1-Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologieet al, editors. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie"},{"key":"761_CR7","doi-asserted-by":"publisher","first-page":"14674","DOI":"10.1038\/s41598-021-94220-6","volume":"11","author":"D Garc\u00eda-Azor\u00edn","year":"2021","unstructured":"Garc\u00eda-Azor\u00edn\u00a0D, Sierra \u00c1, Trigo\u00a0J et al (2021) Frequency and phenotype of headache in covid-19: a\u00a0study of 2194 patients. Sci Rep 11:14674","journal-title":"Sci Rep"},{"key":"761_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/brainsci11060760","volume":"11","author":"JA Gonz\u00e1lez-Hermosillo","year":"2021","unstructured":"Gonz\u00e1lez-Hermosillo\u00a0JA, Mart\u00ednez-L\u00f3pez\u00a0JP, Carrillo-Lamp\u00f3n\u00a0SA et al (2021) Post-acute COVID-19\u00a0symptoms, a\u00a0potential link with myalgic encephalomyelitis\/chronic fatigue syndrome: a\u00a06-month survey in a\u00a0Mexican cohort. Brain Sci 11:760","journal-title":"Brain Sci"},{"key":"761_CR9","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1007\/s00415-022-11225-5","volume":"269","author":"A Gonzalez-Martinez","year":"2022","unstructured":"Gonzalez-Martinez\u00a0A, Guerrero-Peral \u00c1L, Arias-Rivas\u00a0S et al (2022) Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. J\u00a0Neurol 269:5702\u20135709","journal-title":"J Neurol"},{"key":"761_CR10","first-page":"719","volume":"59","author":"T Grande","year":"2023","unstructured":"Grande\u00a0T, Grande\u00a0B, Gerner\u00a0P et\u00a0al (2023) The role of psychotherapy in the care of patients with Myalgic encephalomyelitis\/chronic fatigue syndrome. Ann Univ Mariae Curie Sklodowska [Med] 59:719","journal-title":"Ann Univ Mariae Curie Sklodowska [Med]"},{"key":"761_CR11","unstructured":"Grobe TG, Bessel S, Institut f\u00fcr angewandte Qualit\u00e4tsf\u00f6rderung und Forschung (2022) Jahre Coronapandemie: Wie geht es Deutschlands Besch\u00e4ftigten? Teil\u00a02. In: Techniker Krankenkasse. https:\/\/www.tk.de\/resource\/blob\/2130932\/70a0d93d19f6444f06310379441bd046\/gesundheitsreport-2022-data.pdf. Zugegriffen: 16. Sept. 2023"},{"key":"761_CR12","first-page":"48","volume":"120","author":"M Hallek","year":"2023","unstructured":"Hallek\u00a0M, Adorjan\u00a0K, Behrends\u00a0U et al (2023) Post-COVID Syndrome. Dtsch \u00c4rztebl Int 120:48\u201355","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"761_CR13","first-page":"47","volume":"3","author":"A Houlton","year":"2015","unstructured":"Houlton\u00a0A, Christie\u00a0MM, Smith\u00a0B et al (2015) Long-term follow-up of multi-disciplinary outpatient treatment for chronic fatigue syndrome\/myalgic encephalopathy. Fatigue: Biomed Health Behav 3:47\u201358","journal-title":"Fatigue: Biomed Health Behav"},{"key":"761_CR14","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2023) Myalgische Enzephalomyelitis \/ Chronic Fatigue Syndrome (ME\/CFS) \u2013 Aktueller Kenntnisstand. In:Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen. https:\/\/www.iqwig.de\/download\/n21-01_me-cfs-aktueller-kenntnisstand_abschlussbericht_v1-0.pdf. Zugegriffen: 16. Sept. 2023"},{"key":"761_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/neurolint15010001","volume":"15","author":"LA Jason","year":"2022","unstructured":"Jason\u00a0LA, Dorri\u00a0JA (2022) ME\/CFS and post-Exertional malaise among patients with long COVID. Neurol Int 15:1\u201311","journal-title":"Neurol Int"},{"key":"761_CR16","unstructured":"KBV (2023) \u00d6ffentliche Anh\u00f6rung im Ausschuss f\u00fcr Gesundheit des Dt. Bundestages am 19.\u00a0April 2023. https:\/\/www.bundestag.de\/resource\/blob\/943000\/60468062de2e557ef6436afb4e5c9173\/20_14_0095-5-_Kassenaerztliche-Bundesvereinigung_ME-CFS_nicht-barrierefrei-data.pdf. Zugegriffen: 16. Sept. 2023 (Stellungnahme der KBV zum Antrag der CDU\/CSU-Bundestagsfraktion \u201eME\/CFS-Bretroffene sowie deren Angeh\u00f6rigen helfen \u2013 F\u00fcr eine bessere Gesundheits- sowie Therapieversorgung, Aufkl\u00e4rung und Anerkennung\u201c (BT-DRS.: 20\/4886 vom 14.\u00a0Dezember 2022))"},{"key":"761_CR17","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","volume":"13","author":"C Kedor","year":"2022","unstructured":"Kedor\u00a0C, Freitag\u00a0H, Meyer-Arndt\u00a0L et al (2022) A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun 13:5104","journal-title":"Nat Commun"},{"key":"761_CR18","doi-asserted-by":"crossref","unstructured":"Kielland A, Liu J, Jason LA (2023) Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway. J\u00a0Health Psychol 13591053231169191:","DOI":"10.1177\/13591053231169191"},{"key":"761_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1055\/a-1946-3230","volume":"76","author":"A Koczulla","year":"2022","unstructured":"Koczulla\u00a0A, Ankermann\u00a0T, Behrends\u00a0U et al (2022) S1-Leitlinie Long\u2011\/Post-COVID. Pneumologie 76:855\u2013907","journal-title":"Pneumologie"},{"key":"761_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s44266-023-00045-z","volume":"99","author":"N Kornder","year":"2023","unstructured":"Kornder\u00a0N, Baum\u00a0E, Maisel\u00a0P et al (2023) M\u00fcdigkeit \u2013 Update der S3-Leitlinie. Z\u00a0Allg Med 99:127\u2013132","journal-title":"Z Allg Med"},{"key":"761_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s13760-021-01790-3","volume":"122","author":"AV Krymchantowski","year":"2022","unstructured":"Krymchantowski\u00a0AV, Silva-Neto\u00a0RP, Jevoux\u00a0C et al (2022) Indomethacin for refractory COVID or post-COVID headache: a\u00a0retrospective study. Acta Neurol Belg 122:465\u2013469","journal-title":"Acta Neurol Belg"},{"key":"761_CR22","doi-asserted-by":"crossref","unstructured":"Lemh\u00f6fer C, Koczulla AR, Meissner W et al (2023) Aktualisierte S1-Leitlinie Long\/Post-COVID: Relevante Aspekte f\u00fcr die Schmerzmedizin. Schmerz: 1\u20138","DOI":"10.1007\/s00482-023-00704-x"},{"key":"761_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050510","author":"L Nacul","year":"2021","unstructured":"Nacul\u00a0L, Authier\u00a0FJ, Scheibenbogen\u00a0C et\u00a0al (2021) European Network on Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME\/CFS in Europe. Med (Kaunas). https:\/\/doi.org\/10.3390\/medicina57050510","journal-title":"Med (Kaunas)"},{"key":"761_CR24","unstructured":"NICE (2021) Myalgic encephalomyelitis (or encephalopathy)\/chronic fatigue syndrome: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng206. Zugegriffen: 16. Sept. 2023 (Methods)"},{"key":"761_CR25","unstructured":"(2023) Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30\u00a0March 2023. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/datasets\/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk. Zugegriffen: 16. Sept. 2023 (An additional data table contains the data covering the four weeks to 2025 February 2023. Experimental Statistics.)"},{"key":"761_CR26","doi-asserted-by":"publisher","unstructured":"Peo LC, Wiehler K, Paulick J et al (2023) Pediatric and Adult Patients with ME\/CFS following COVID-19: A\u00a0Structured Approach to Diagnosis Using the Munich Berlin Symptom Questionnaire (MBSQ). https:\/\/doi.org\/10.1101\/2023.08.23.23293081 (medRxiv:2023.2008. 2023.23293081)","DOI":"10.1101\/2023.08.23.23293081"},{"key":"761_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00482-019-0374-2","volume":"33","author":"M Pfingsten","year":"2019","unstructured":"Pfingsten\u00a0M, Arnold\u00a0B, Boger\u00a0A et al (2019) Cross-sectoral interdisciplinary multimodal pain therapy : Recommendations on structural and process parameters of the ad hoc commission \u201cInterdisciplinary Multimodal Pain Therapy\u201d of the German Pain Society (Deutsche Schmerzgesellschaft e. V.). Schmerz 33:191\u2013203","journal-title":"Schmerz"},{"key":"761_CR28","unstructured":"Rajan S, Khunti K, Alwan N et\u00a0al (2021) In the wake of the pandemic: preparing for long COVID. https:\/\/apps.who.int\/iris\/handle\/10665\/339629. Zugegriffen: 16. Sept. 2023"},{"key":"761_CR29","first-page":"830","volume":"63","author":"H Renz-Polster","year":"2022","unstructured":"Renz-Polster\u00a0H, Scheibenbogen\u00a0C (2022) Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis\/chronic fatigue syndrome. Inn Med (heidelb) 63:830\u2013839","journal-title":"Inn Med (heidelb)"},{"key":"761_CR30","doi-asserted-by":"publisher","first-page":"e1004122","DOI":"10.1371\/journal.pmed.1004122","volume":"19","author":"M Roessler","year":"2022","unstructured":"Roessler\u00a0M, Tesch\u00a0F, Batram\u00a0M et al (2022) Post-COVID-19-associated morbidity in children, adolescents, and adults: A\u00a0matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med 19:e1004122","journal-title":"PLoS Med"},{"key":"761_CR31","unstructured":"Scheibenbogen C, Bellmann-Strobl J, Rei\u00dfhauer A et al (2023) Myalgische Enzephalomyelitis\/Chronisches Fatigue-Syndrom: Interdisziplin\u00e4r versorgen. Dtsch \u00c4tzteblatt: A908\u2013A914"},{"key":"761_CR32","unstructured":"Scheibenbogen C, Renz-Polster H, Hohberger B et al (2023) Post COVID und Post-Vakzin-Syndrom: Die Pandemie nach der Pandemie. Dtsch \u00c4rztebl: A566\u2013A570"},{"key":"761_CR33","first-page":"26","volume":"9","author":"C Scheibenbogen","year":"2019","unstructured":"Scheibenbogen\u00a0C, Wittke\u00a0K, Hanitsch\u00a0L et\u00a0al (2019) Chronisches Fatigue Syndrom\/CFS: Praktische Empfehlungen zur Diagnostik und Therapie. \u00c4rztebl Sachsen 9:26\u201330","journal-title":"\u00c4rztebl Sachsen"},{"key":"761_CR34","unstructured":"Sch\u00f6ning D (2023) Long Covid Deutschland. https:\/\/longcoviddeutschland.org\/ambulanzen\/. Zugegriffen: 16. Sept. 2023"},{"key":"761_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-022-01450-8","volume":"23","author":"C Tana","year":"2022","unstructured":"Tana\u00a0C, Bentivegna\u00a0E, Cho\u00a0SJ et\u00a0al (2022) Long COVID headache. J\u00a0Headache Pain 23:93","journal-title":"J Headache Pain"},{"key":"761_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fped.2018.00349","volume":"6","author":"C Van Campen","year":"2018","unstructured":"Van Campen\u00a0C, Rowe\u00a0PC, Visser\u00a0FC (2018) Low sensitivity of abbreviated tilt table testing for diagnosing postural tachycardia syndrome in adults with ME\/CFS. Front Pediatr 6:349","journal-title":"Front Pediatr"},{"key":"761_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1359105321990810","volume":"27","author":"M Vink","year":"2022","unstructured":"Vink\u00a0M, Vink-Niese\u00a0A (2022) The draft updated NICE guidance for ME\/CFS highlights the unreliability of subjective outcome measures in non-blinded trials. J\u00a0Health Psychol 27:9\u201312","journal-title":"J Health Psychol"},{"key":"761_CR38","doi-asserted-by":"crossref","unstructured":"Vink M, Vink-Niese A (2022) The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME\/CFS. Healthc (basel) 10:","DOI":"10.3390\/healthcare10050898"},{"key":"761_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s40122-023-00492-3","volume":"12","author":"LD Williams","year":"2023","unstructured":"Williams\u00a0LD, Zis\u00a0P (2023) COVID-19-related burning eye syndrome and burning mouth syndrome: a\u00a0systematic review and meta-analysis. Pain Ther 12:621\u2013630","journal-title":"Pain Ther"},{"key":"761_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12967-021-03143-3","volume":"19","author":"KJ Wirth","year":"2021","unstructured":"Wirth\u00a0KJ, Scheibenbogen\u00a0C, Paul\u00a0F (2021) An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. J\u00a0Transl Med 19:471","journal-title":"J Transl Med"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-023-00761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-023-00761-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-023-00761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T15:05:16Z","timestamp":1716476716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-023-00761-2"}},"subtitle":["Besonderheiten, Fallstricke und Modellkonzept","Features, pitfalls and model concept"],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1007\/s00482-023-00761-2","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"type":"print","value":"0932-433X"},{"type":"electronic","value":"1432-2129"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"19 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Behrends erhielt Forschungsgelder zu PCS und\/oder ME\/CFS von Bund (BMG, BMBF), Land Bayern (StMWK, StMGP) sowie den Weidenhammer-Z\u00f6bele\u2011, Menschen-f\u00fcr-Kinder- und Lost-Voices-Stiftungen. B.\u00a0Luchting, B.\u00a0Eigner, S.\u00a0Stojanov, C.\u00a0Warlitz, M.\u00a0Haegele, E.\u00a0Neuwirth, L.\u00a0Mihatsch und H.P.\u00a0Richter geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}